BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23408651)

  • 21. Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling.
    Mandal CC; Das F; Ganapathy S; Harris SE; Choudhury GG; Ghosh-Choudhury N
    J Biol Chem; 2016 Jan; 291(3):1148-61. PubMed ID: 26472929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperactivation of MEK/ERK pathway by Ca
    Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
    Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
    Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
    Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
    Xia WF; Jung JU; Shun C; Xiong S; Xiong L; Shi XM; Mei L; Xiong WC
    J Bone Miner Res; 2013 Oct; 28(10):2122-35. PubMed ID: 23649480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
    Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
    Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment.
    Xu H; Lu X; Li M; Huang X; Yao N; Gan H; Huang X; Zhao Z; Hu Z; Zhao X; Lai Y; Li M; Chen S; Chen Y; Huang D
    Phytomedicine; 2024 Jun; 128():155501. PubMed ID: 38471318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.
    Weivoda MM; Ruan M; Hachfeld CM; Pederson L; Howe A; Davey RA; Zajac JD; Kobayashi Y; Williams BO; Westendorf JJ; Khosla S; Oursler MJ
    J Bone Miner Res; 2016 Jan; 31(1):65-75. PubMed ID: 26189772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic inhibition or global deletion of CaMKK2 protects against post-traumatic osteoarthritis.
    Mével E; Shutter JA; Ding X; Mattingly BT; Williams JN; Li Y; Huls A; Kambrath AV; Trippel SB; Wagner D; Allen MR; O'Keefe R; Thompson WR; Burr DB; Sankar U
    Osteoarthritis Cartilage; 2022 Jan; 30(1):124-136. PubMed ID: 34506942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CaMKK2 is not involved in contraction-stimulated AMPK activation and glucose uptake in skeletal muscle.
    Negoita F; Addinsall AB; Hellberg K; Bringas CF; Hafen PS; Sermersheim TJ; Agerholm M; Lewis CTA; Ahwazi D; Ling NXY; Larsen JK; Deshmukh AS; Hossain MA; Oakhill JS; Ochala J; Brault JJ; Sankar U; Drewry DH; Scott JW; Witczak CA; Sakamoto K
    Mol Metab; 2023 Sep; 75():101761. PubMed ID: 37380024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
    Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
    J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenylate cyclase and calmodulin-dependent kinase have opposite effects on osteoclastogenesis by regulating the PKA-NFATc1 pathway.
    Yoon SH; Ryu Jy; Lee Y; Lee ZH; Kim HH
    J Bone Miner Res; 2011 Jun; 26(6):1217-29. PubMed ID: 21611964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
    Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
    Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV.
    Kokubo M; Nishio M; Ribar TJ; Anderson KA; West AE; Means AR
    J Neurosci; 2009 Jul; 29(28):8901-13. PubMed ID: 19605628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gambogic acid inhibits osteoclast formation and ovariectomy-induced osteoporosis by suppressing the JNK, p38 and Akt signalling pathways.
    Ma J; Ma Y; Liu X; Chen S; Liu C; Qin A; Fan S
    Biochem J; 2015 Aug; 469(3):399-408. PubMed ID: 26205493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca
    Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X
    Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isovaleric acid ameliorates ovariectomy-induced osteoporosis by inhibiting osteoclast differentiation.
    Cho KM; Kim YS; Lee M; Lee HY; Bae YS
    J Cell Mol Med; 2021 May; 25(9):4287-4297. PubMed ID: 33768674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesis.
    Kim HJ; Lee J; Lee GR; Kim N; Lee HI; Kwon M; Kim NY; Park JH; Kang YH; Song HJ; Kim T; Shin DM; Jeong W
    J Cell Physiol; 2021 Dec; 236(12):8239-8252. PubMed ID: 34192358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.